Tender Offer | ₹19.14 Crores | Listed at BSE, NSE | Thu, Dec 18, 2025 - Wed, Dec 24, 2025
Nureca Ltd. Buyback is a tender offer for the repurchase of up to 0.06 crore equity shares at a buyback price of ₹330 per share with a face value of ₹10 per share, aggregating to ₹19.14 crores.
The record date for determining eligible shareholders is Dec 12, 2025. Shareholders holding equity shares as on the record date are eligible to participate in the buyback.
The buyback opens on Dec 18, 2025 and closes on Dec 24, 2025, with the last date for receipt of tender forms being Dec 24, 2025.
The finalisation of buyback acceptance is expected on Dec 30, 2025, followed by settlement of bids on Jan 1, 2026.
Mefcom Capital Markets Ltd. is the Manager to the Buyback and Alankit Assignments Ltd. is the Registrar and Mefcom Securities Limited is the Registered Broker to the Buyback.
Investors are advised to refer to the Nureca Ltd. Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.
Offer Opening Date
Thu, Dec 18, 2025
Offer Closing Date
Wed, Dec 24, 2025
Buyback Price
₹330 per share
Record Date
December 12, 2025
| Category | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. | 3,29,093 |
| General Category for all other Eligible Shareholders | 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. | 2,50,907 |
Nureca Limited's revenue increased by 19% and profit after tax (PAT) rose by 147% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Total Income | 122.10 | 102.44 | 118.43 |
| Profit After Tax | 0.85 | -1.79 | -8.25 |
| Amount in ₹ Crore | |||
Incorporated in 2016, Nureca Limited is a healthcare and wellness company focused on making clinically reliable home healthcare products accessible to individuals, caregivers, and medical practitioners in India and select international markets. The company combines medical‑grade technology with consumer-friendly design to help people monitor, manage and improve their health from the comfort of their homes.
Nureca operates at the convergence of these trends by offering devices that can reduce dependence on frequent clinical visits and support continuous monitoring. The company’s digital‑led distribution, broad portfolio and consumer‑centric branding place it well to participate in the structural growth of India’s home healthcare category.
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jan-2025 | 294.50 | 245.00 | 268.88 |
| Jan-2025 | 343.60 | 225.85 | 263.56 |
| Jan-2025 | 278.40 | 225.95 | 246.70 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jan-2025 | 293.00 | 247.00 | 267.21 |
| Jan-2025 | 343.00 | 226.84 | 263.74 |
| Jan-2025 | 278.40 | 226.00 | 246.80 |
The Company is undertaking the Buyback after taking into account the Company's medium-term strategic and operational cash requirements, as well as the need to return surplus funds to the members in an effective and efficient manner. The proposed Buyback will help the Company achieve the following objectives:
Nureca Ltd.
101 Office Number, Udyog Bhavan
1st Floor, Sonawala Lane,
Goregaon East
Mumbai, Maharashtra, 400063
Lead Manager(s)
Registered Broker
The Nureca Limited Buyback 2025 opens on December 18, 2025, and closes on December 24, 2025.
Last date to be eligible to participate in buyback is December 11, 2025.
The Nureca Limited Buyback 2025 is a Tender Offer.
Nureca Limited Buyback 2025 Schedule
| Buyback Opening Date | December 18, 2025 |
| Buyback Closing Date | December 24, 2025 |
| Last Date for receipt of Tender Forms | December 24, 2025 |
| Finalisation of Buyback Acceptance | December 30, 2025 |
| Last Date for settlment of bids | January 1, 2026 |
| Last Date for Extinguishment of Shares | January 12, 2026 |
The Nureca Limited Buyback 2025 is being offered at Rs ₹330 per share.
| Category | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. | 3,29,093 |
| General Category for all other Eligible Shareholders | 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. | 2,50,907 |
The issue size of Nureca Limited Buyback 2025 is 5,80,000 equity shares at ₹330 per share aggregating up to ₹19.14 Crores.
The Company is undertaking the Buyback after taking into account the Company's medium-term strategic and operational cash requirements, as well as the need to return surplus funds to the members in an effective and efficient manner. The proposed Buyback will help the Company achieve the following objectives:
All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.
The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.
The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.
The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.
The Nureca Limited Buyback 2025 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
